From: Ayse Tezcan [mailto:aztezcan@ucdavis.edu]
Sent: Thursday, December 03, 2015 5:17 PM
To: Meghan A Soulsby
Cc: Joy Melnikow; Shauna Durbin; Alinea Noronha; Barbara M. Galligan; Ganz Patricia M.D.; Van Dyk, Kathleen (KVanDyk@mednet.ucla.edu); Benjamin Chan; Bandos, Hanna; Rivera, Donna (NIH/NCI) F; Freedman, Andrew (NIH/NCI) [E]; Kirstin D Truitt
Subject: Re: Reminder NCI Systematic Review Call - 12/7 @1:30 PST
Here is another study just came out today in JAMA Oncology again investigating cognitive effects of chemotherapy.
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. Shelli R. Kesler, PhD; DouglasW. Blayney, MD
From: Ayse Tezcan [mailto:aztezcan@ucdavis.edu] Sent: Thursday, December 03, 2015 5:17 PM To: Meghan A Soulsby Cc: Joy Melnikow; Shauna Durbin; Alinea Noronha; Barbara M. Galligan; Ganz Patricia M.D.; Van Dyk, Kathleen (KVanDyk@mednet.ucla.edu); Benjamin Chan; Bandos, Hanna; Rivera, Donna (NIH/NCI) F; Freedman, Andrew (NIH/NCI) [E]; Kirstin D Truitt Subject: Re: Reminder NCI Systematic Review Call - 12/7 @1:30 PST
Here is another study just came out today in JAMA Oncology again investigating cognitive effects of chemotherapy. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. Shelli R. Kesler, PhD; DouglasW. Blayney, MD
coi150082.pdf ced150028.pdf